Articles related to Pulmonology

Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.

ICU mortality rates for Legionella pneumonia can reach up to 41.7%, with immunocompromised patients facing particularly high risk – making proper diagnosis and treatment crucial in severe cases.

“Pulmonary arterial hypertension, a rare [form] of pulmonary hypertension, has a disproportionate impact on women,” wrote investigator Vallerie V. McLaughlin, MD, and co-authors in a published abstract for the study.

Bevacizumab therapy demonstrated marked improvement in both epistaxis severity and abdominal symptoms, despite unchanged radiographic appearance of hepatic AVMs, suggesting therapeutic benefit at the microvasculature level.

The updated COVID-19 vaccines generate a more pronounced and specific immune response against current circulating strains, potentially reducing infection rates and, crucially, severe disease.

The FDA’s approval of new COVID-19 vaccines targeting the KP.2 strain comes amidst concerns about waning immunity and evolving virus variants.